LAM was used as a rule in screening tool for hospitalized adult HIV-infected patients (Malawi) and for ambulatory patients with CD4 <100/μl (Mozambique) and as an additional diagnostic tool for adult HIV-infected TB suspects with CD4 <200/μl (Malawi and Mozambique). This evidence concerns the gene CD4 and tuberculosis.